Forgent Power Solutions Announces Pricing of Initial Public Offering
DAYTON, Minn.–(BUSINESS WIRE)–Forgent Power Solutions, Inc. (“Forgent” or the “Company”), a leading designer and manufacturer of electrical distribution... Read more.
Investor Notice: Shareholder Rights Law Firm Robbins LLP Informs Investors of the Mereo BioPharma Group plc Securities Class Action Lawsuit
SAN DIEGO–(BUSINESS WIRE)–$MREO #Biopharmaceutical—Robbins LLP informs stockholders that a class action was filed on behalf of all investors who... Read more.
Grab Finance Expands Credit Access Across Southeast Asia Using FICO Platform, Delivering 22 Workflows in Six Countries
Region’s leading superapp advances financial inclusion for millions by applying advanced decisioning to behavioral data SINGAPORE–(BUSINESS WIRE)–FICO... Read more.
UPDATE: XTM Inc. Clarifies RPAA-Related Disclosure and Regulatory Continuity
TORONTO–(BUSINESS WIRE)–XTM Inc. (OTCQB: XTMIF | CSE: PAID) (“XTM” or the “Company”) is issuing this clarification regarding language contained... Read more.
Investor Notice: Shareholder Rights Law Firm Robbins LLP Informs Investors of the Oracle Corporation Securities Class Action Lawsuit
SAN DIEGO–(BUSINESS WIRE)–$ORCL #Oracle—Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased... Read more.
Investor Notice: Shareholder Rights Law Firm Robbins LLP Informs Investors of the BlackRock TCP Capital Corp. Securities Class Action Lawsuit
SAN DIEGO–(BUSINESS WIRE)–$TCPC #Banking—Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased... Read more.
JCR Pharmaceuticals’ Research Presentations at WORLDSymposium™ 2026 Showcase Data from Its Investigational Treatments for Lysosomal Storage Disorders
– Presentations Highlight Potential Benefits of Therapies Incorporating J-Brain Cargo®, JCR’s Proprietary, Blood-Brain Barrier-Penetrating Technology –... Read more.
Investor Notice: Shareholder Rights Law Firm Robbins LLP Informs Investors of the Ultragenyx Pharmaceutical Inc. Securities Class Action Lawsuit
SAN DIEGO–(BUSINESS WIRE)–$RARE #Health—Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased... Read more.
Renesas Reports Financial Results for the Year Ended December 31, 2025
TOKYO–(BUSINESS WIRE)–#Renesas–Renesas Electronics Corporation (TSE:6723) today announced consolidated financial results in accordance with IFRS... Read more.
Notice Concerning the Difference between Renesas’ Financial Results for the Year Ended December 31, 2025, and Results in the Previous Period
TOKYO–(BUSINESS WIRE)–#Renesas–Renesas Electronics Corporation (TSE: 6723, “Renesas”), a premier supplier of advanced semiconductor solutions,... Read more.